Elina Kivekäs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elina Kivekäs has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Minna M. Mäenpää
Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Finnish Cancer Center Mid, Tampere, Finland
3 shared publicationsSynnöve Staff
Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Finnish Cancer Center Mid, Tampere, Finland
3 shared publicationsEija I. Tomás
Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; FICAN Mid
1 shared publicationHeini S.A. Huhtala
Faculty of Social Sciences, Tampere University, Tampere, Finland
1 shared publicationJohanna U. Mäenpää
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; FICAN Mid
1 shared publicationKari Nieminen
Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; FICAN Mid
1 shared publication
Latest Publications
- Open Access
- 21 July 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 736
Robotic-assisted surgery and sentinel lymph node biopsy in morbidly obese endometrial cancer patients: a retrospective cohort study
Obesity is associated with a worse prognosis in endometrial cancer (EC) patients. While robotic surgery has overcome many technical challenges of morbid obesity, lymphadenectomies are still performed less frequently, leading to understaging and potential undertreatment in highly obese patients. We aimed to assess whether robotic-assisted laparoscopy (RAL) and the implementation of sentinel lymph node biopsy (SLNB) have enabled guideline-compliant nodal staging in morbidly obese patients. Surgical and oncological outcomes were also assessed. This retrospective single-center cohort study included all patients who underwent primary robotic surgery for EC at Tampere University Hospital, Finland, between March 2009 and December 2022. BMI stratified patients into morbidly obese (BMI ≥ 40 kg/m 2 ) and non-morbidly obese (< 40 kg/m 2 ) groups. Primary outcomes were nodal staging rates, bilateral sentinel lymph node (SLN) detection rates, and surgical complications. Cox regression analysis was used to assess survival outcomes. Of the 749 patients, 127 (17%) were morbidly obese and 622 (83%) had a BMI < 40. Following the implementation of SLNB, successful nodal staging was achieved in 87% of morbidly obese patients, with a bilateral SLN detection rate of 78%. Lymphadenectomies were performed less frequently in morbidly obese patients. Intraoperative and postoperative complication rates did not differ between BMI groups. No conversions were recorded in the final five years of the study. Higher BMI was associated with poorer overall survival (HR 1.04, 95% CI 1.02–1.07, p = 0.002), but not with progression-free survival or disease-specific survival. With robotic-assisted laparoscopy and SLNB, appropriate staging was achieved in most morbidly obese patients in this cohort.
- 21 July 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 736
Open AccessRobotic-assisted surgery and sentinel lymph node biopsy in morbidly obese endometrial cancer patients: a retrospective cohort study
Obesity is associated with a worse prognosis in endometrial cancer (EC) patients. While robotic surgery has overcome many technical challenges of morbid obesity, lymphadenectomies are still performed less frequently, leading to understaging and potential undertreatment in highly obese patients. We aimed to assess whether robotic-assisted laparoscopy (RAL) and the implementation of sentinel lymph node biopsy (SLNB) have enabled guideline-compliant nodal staging in morbidly obese patients. Surgical and oncological outcomes were also assessed. This retrospective single-center cohort study included all patients who underwent primary robotic surgery for EC at Tampere University Hospital, Finland, between March 2009 and December 2022. BMI stratified patients into morbidly obese (BMI ≥ 40 kg/m 2 ) and non-morbidly obese (< 40 kg/m 2 ) groups. Primary outcomes were nodal staging rates, bilateral sentinel lymph node (SLN) detection rates, and surgical complications. Cox regression analysis was used to assess survival outcomes. Of the 749 patients, 127 (17%) were morbidly obese and 622 (83%) had a BMI < 40. Following the implementation of SLNB, successful nodal staging was achieved in 87% of morbidly obese patients, with a bilateral SLN detection rate of 78%. Lymphadenectomies were performed less frequently in morbidly obese patients. Intraoperative and postoperative complication rates did not differ between BMI groups. No conversions were recorded in the final five years of the study. Higher BMI was associated with poorer overall survival (HR 1.04, 95% CI 1.02–1.07, p = 0.002), but not with progression-free survival or disease-specific survival. With robotic-assisted laparoscopy and SLNB, appropriate staging was achieved in most morbidly obese patients in this cohort.
- 6 August 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 234 (1) , e10
Long-term oncological outcomes support the use of robotic-assisted surgery in endometrial cancer: a response
- 6 August 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 234 (1) , e10
Long-term oncological outcomes support the use of robotic-assisted surgery in endometrial cancer: a response
- 3 May 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 233 (3) , e112
Robotic-assisted surgery for endometrial cancer: the need for further randomized trials
- 3 May 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 233 (3) , e112
Robotic-assisted surgery for endometrial cancer: the need for further randomized trials
- Top Cited PapersOpen Access
- 23 August 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (3) , 304.e1-304.e8
Robotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial
- 23 August 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (3) , 304.e1-304.e8
Top Cited PapersOpen AccessRobotic-assisted versus conventional laparoscopic surgery for endometrial cancer: long-term results of a randomized controlled trial